Table 1.
Baseline characteristics of participants in four treatment groups.
| Sibutramine Alone | Lifestyle Modification Alone |
Combined Therapy | Sibutramine Plus Brief Therapy |
|
|---|---|---|---|---|
| (N = 45) | (N = 47) | (N = 53) | (N = 49) | |
| Gender (no. subjects) | ||||
| Female | 37 | 39 | 45 | 41 |
| Male | 8 | 8 | 8 | 8 |
| Race or ethnicity | ||||
| White | 26 | 30 | 36 | 35 |
| Black | 18 | 15 | 16 | 11 |
| Hispanic | 1 | 2 | 1 | 2 |
| Unknown | 0 | 0 | 0 | 1 |
| Age (yr) | 42.2 ± 9.8a | 42.9 ± 9.9 | 44.4 ± 10.6 | 44.8 ± 10.1 |
| Weight (kg) | 106.7 ± 15.5 | 103.5 ± 14.3 | 106.5 ± 17.2 | 106.0 ± 18.6 |
| Height (cm) | 167.3 ± 8.3 | 166.5 ± 7.7 | 167.6 ± 8.4 | 167.6 ± 8.4 |
| BMI (kg/m2) | 38.0 ± 3.9 | 37.3 ± 3.8 | 37.8 ± 4.1 | 37.6 ± 4.6 |
| Baseline BDI score | 8.1 ± 6.9 | 9.1 ± 8.0 | 8.0 ± 6.5 | 7.3 ± 6.7 |
a
Values are presented as mean ± SD. Age and race/ethnicity were self-reported. Chi-square tests (or analysis of variance) revealed no significant differences among the four groups on any of the baseline characteristics. Note: BMI = body mass index, BDI = Beck Depression Inventory